Biozeus

WORKWITHUS

Researcher

PROJECT SELECTION CRITERIA HOW BIOZEUS WORKS

Project selection
criteria

Biozeus employs a rigorous process for identification, evaluation and development of promising early-stage drug technologies and compounds submitted by Brazilian university researchers. Our specialists work with the researcher and the institution's technology transfer office to evaluate the scientific merit and therapeutic and commercial potential of candidate projects.

Initial project selection is based on the following key requirements:

  • POTENTIAL TO ADDRESS A SIGNIFICANT UNMET MEDICAL NEED
  • EXCELLENT, INNOVATIVE SCIENCE
  • POTENTIAL FOR A SOLID IP POSITION
  • POTENTIAL FOR COMMERCIA-LIZATION
  • WILLING AND ENGAGED PRINCIPAL INVESTIGATOR(S)

how biozeus works

We support two levels of projects:

  • Incubation Projects are small, 3-6 month projects undertaken to determine whether a Development Project is warranted. Examples include conducting experiments to confirm available studies and data or clarifying specific aspects supporting the decision-making process.
  • Development Projects are larger projects, typically including 2-3 milestones achieved over a period of several years. Development Projects are undertaken to advance the project toward commercialization. They are reviewed by several experts and must be approved by the Board of Biozeus before initiation.

Once an approved project, a Biozeus Project Manager with relevant expertise is assigned and responsible for:

  • ACTING AS THE PRIMARY LIAISON WITH THE RESEARCHER
  • BRINGING TOGETHER A TEAM OF COLLABORATORS
  • DEVELOPING A PROJECT PLAN
  • ENSURING THE EFFECTIVE DEVELOPMENT AND EXECUTION OF THE PROJECT PLAN

Our approach to project management sets well-defined milestones, Go/No-Go decision points and reporting processes that mirror industry best practices. Projects with more promising data are advanced, while those requiring further research are returned to the principal investigator for further exploration or terminated. This approach reduces risk by ensuring that only those technologies with the strongest scientific and business potential are progressed to the next stage.